Differential Association Between Cumulative Dose of 5α-Reductase Inhibitors and Mortality

    March 2025 in “ Scientific Reports ”
    Jinhyun Kim, Suk‐Yong Jang, Eun‐Cheol Park
    Image of study
    TLDR Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.
    This study involving 17,714 participants with benign prostatic hyperplasia (BPH) or androgenic alopecia (AGA) found a dose-dependent relationship between 5α-reductase inhibitors (5-ARIs) and mortality. Ever-users of 5-ARIs had a 16.9% increased risk of all-cause mortality compared to never-users. However, a cumulative dose of less than 730 defined daily doses (cDDDs) was linked to higher mortality, while doses over 5,840 cDDDs were associated with a significantly lower risk. Both dutasteride and finasteride users showed higher mortality risks at lower doses, but higher doses reduced the risk. The study also noted that higher doses decreased mortality from cardiovascular diseases (CVDs), while lower doses increased suicide risk. The findings suggest that maintaining a high 5-ARI dosage may be protective, but careful monitoring is needed, especially for those on low doses. The study's limitations include its focus on Korean participants and the inability to establish causality. Further research is needed to confirm these associations in diverse populations.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results

    Related Community Posts Join

    6 / 127 results

      community Fresh off the press: Dutasteride may cause chronic infertility

      in Research/Science  641 upvotes 3 months ago
      Dutasteride may cause chronic infertility by reducing semen volume and motility, with concerns about irreversible prostate fibrosis. Users consider switching to finasteride or using treatments like minoxidil and microneedling, weighing hair preservation against fertility.

      community Having androgen receptor density and sensitivity at wrong f*ing place

      in Satire  7 upvotes 9 months ago
      The conversation discusses hair loss treatments, focusing on the use of topical minoxidil, microneedling, finasteride, and dutasteride, while debating the role of testosterone and DHT in hair loss. It also touches on the potential liver health impacts of these treatments and the genetic sensitivity of hair follicles to androgens.

      community A hill on which I will die: The DHT itch absolutely exists

      in Research/Science  210 upvotes 1 year ago
      The DHT itch is linked to hair loss and persists despite finasteride use; switching to dutasteride helped alleviate the itch and promoted regrowth. Some users suggest seborrheic dermatitis as a cause and recommend treatments like medicated shampoos, vitamin D, and minoxidil.

      community risks with finasteride and dutasteride

      in Research/Science  144 upvotes 2 weeks ago
      Finasteride and dutasteride have potential risks, including post-finasteride syndrome, but are commonly used for hair loss. RU58841, minoxidil, and needling are suggested as alternatives, though all treatments carry risks.

    Similar Research

    5 / 1000+ results